Microbot Medical Inc. announced that Professor Gerry O'Sullivan, a key opinion leader (KOL) from Ireland, has joined the company's Scientific Advisory Board (SAB). The company believes the combination of his academic and medical experience will be invaluable while it seeks to establish Centers of Excellence throughout the U.S. and Europe in preparation for human clinical trials. Prior to Galway Clinic, and during his time in the U.S., Professor O'Sullivan worked as a Fellow at Stanford University Medical Centre and as a Consultant at Rush University Medical Centre.

Professor O'Sullivan specializes in venous disease, with expertise in Deep Venous Thrombus (DVT) removal, Inferior Vena Cava (IVC) reconstruction and IVC filter indications. Annually, Professor O'Sullivan performs large volumes of prostate and uterine fibroid embolizations, as well as the full array of Interventional procedures. Professor O'Sullivan has over 25 years' experience and is a Fellow of the Society of Interventional Radiology (SIR), as well as a Fellow of the European Board of Interventional Radiology (EBIR).

Professor O'Sullivan, who is the primary author in multiple publications concerning the deep venous system, serves on the Executive Committee of Cardiovascular and Interventional Radiological Society of Europe (CIRSE) along with being Vice Chair of the Scientific Program Committee (SPC) for the CIRSE's Annual Meeting.